CASTLE BIOSCIENCES, INC. Cost of Goods and Services Sold
CASTLE BIOSCIENCES, INC. (CSTL) reported Cost of Goods and Services Sold of $15.82 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2022-02-28
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for the quarter ending 2021-03-31 was $3.03M, a 26.64% increase year-over-year.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for the quarter ending 2020-12-31 was $2.67M, a 32.92% increase year-over-year.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for the quarter ending 2020-09-30 was $2.48M, a 44.91% increase year-over-year.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for the quarter ending 2020-06-30 was $2.15M, a 7.68% increase year-over-year.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for fiscal 2021 was $15.82M, a 63.37% increase from fiscal 2020.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for fiscal 2020 was $9.69M, a 32.49% increase from fiscal 2019.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for fiscal 2019 was $7.31M, a 38.00% increase from fiscal 2018.
- CASTLE BIOSCIENCES, INC. cost of goods and services sold for fiscal 2018 was $5.30M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | $15.82M 10-K · filed 2022-02-28 | ||||||
| 2021-03-31 | $3.03M 10-Q · filed 2021-05-10 | $5.70M derived: sum of 2 quarters · filed 2022-02-28 | $8.18M derived: sum of 3 quarters · filed 2022-02-28 | $10.32M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.15M derived: sum of 2 quarters · filed 2022-02-28 | $7.29M derived: sum of 3 quarters · filed 2022-02-28 | $9.69M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $2.48M 10-Q · filed 2020-11-09 | $4.62M derived: sum of 2 quarters · filed 2020-11-09 | $7.01M 10-Q · filed 2020-11-09 | $9.02M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-06-30 | $2.15M 10-Q · filed 2020-08-10 | $4.54M 10-Q · filed 2020-08-10 | $6.55M derived: sum of 3 quarters · filed 2021-05-10 | $8.26M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-03-31 | $2.39M 10-Q · filed 2021-05-10 | $4.40M derived: sum of 2 quarters · filed 2021-05-10 | $6.11M derived: sum of 3 quarters · filed 2021-05-10 | $8.10M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.72M derived: sum of 2 quarters · filed 2021-03-11 | $5.71M derived: sum of 3 quarters · filed 2021-03-11 | $7.31M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $1.71M 10-Q · filed 2020-11-09 | $1.71M 10-Q · filed 2019-11-12 | $3.70M derived: sum of 2 quarters · filed 2020-11-09 | $5.30M 10-Q · filed 2020-11-09 | $5.30M 10-Q · filed 2019-11-12 | $6.67M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $1.99M 10-Q · filed 2020-08-10 | $1.99M 10-Q · filed 2019-09-03 | $3.59M 10-Q · filed 2020-08-10 | $3.59M 10-Q · filed 2019-09-03 | $4.96M derived: sum of 3 quarters · filed 2020-08-10 | $6.31M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $1.60M 10-Q · filed 2020-05-11 | $2.96M derived: sum of 2 quarters · filed 2020-05-11 | $4.32M derived: sum of 3 quarters · filed 2020-05-11 | $5.64M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.72M derived: sum of 2 quarters · filed 2020-03-10 | $4.04M derived: sum of 3 quarters · filed 2020-03-10 | $5.30M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $1.35M 10-Q · filed 2019-11-12 | $2.68M derived: sum of 2 quarters · filed 2019-11-12 | $3.93M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $1.33M 10-Q · filed 2019-09-03 | $2.58M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |